Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma

Takatoshi Shimauchi(Hamamatsu University School of Medicine), Tetsuya Honda(Hamamatsu University School of Medicine)
NAR Cancer
October 7, 2025
Cited by 1


Related Papers

No related papers found

Powered by citation graph analysis